id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
946814,6ef5ef96-3574-4f95-bd57-02bfdb1eebb8,Q2,HOLLAND & KNIGHT LLP,18466,AMERICAN SOCIETY OF HEMATOLOGY,2010,second_quarter,PHA,Hematology and Oncology drug research and approval issues.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-06-29T13:22:49.667000-04:00
946820,d67793e3-bf4d-4bbd-9971-337eb79870ea,Q2,HOLLAND & KNIGHT LLP,18466,NATIONAL HEMOPHILIA FOUNDATION,2010,second_quarter,PHA,Blood and blood product safety; issues related to blood product approvals; Healthcare Reform legislation-340B program and orphan drugs..,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",40000,,0,0,2010-06-29T13:27:54.447000-04:00
947159,511f60a4-2eaa-46c2-8e08-3d9df26882d9,Q2,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2010,second_quarter,PHA,"Food and Drug Safety Globalization Act
Monitoring Dorgan-Snowe Drug reimportation from Canada
Health Care Reform","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-07-01T19:16:56.360000-04:00
947477,57ed45af-97c0-46ad-a0a6-f0130d24a5a8,Q2,LONG TERM CARE PHARMACY ALLIANCE,400309443,LONG TERM CARE PHARMACY ALLIANCE,2010,second_quarter,PHA,Medicare Part D,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,125000,0,0,2010-07-06T11:28:09.923000-04:00
947574,c765622d-e579-430e-9c45-b5c74e64ae9f,Q2,MR. THEODORE (TED) JONES,20926,PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA,2010,second_quarter,PHA,Trade Association for certain Pharmaceutical Companies,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-07-06T14:16:37.477000-04:00
947627,feeccad0-bb1b-4aa0-b503-6ac94e5763bb,Q2,"NAHIGIAN STRATEGIES, LLC",322897,TEVA PHARMACEUTICALS USA INC,2010,second_quarter,PHA,Issues pertaining to generic pharmaceuticals,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-06T16:16:04.557000-04:00
947929,d58de490-c00e-4e6b-a11d-d2322c7f8ab8,Q2,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2010,second_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,54750,0,0,2010-07-07T15:29:08.027000-04:00
947938,a961ee44-93b8-444a-951e-a917afbdd519,Q2,HANCE SCARBOROUGH,17443,INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION),2010,second_quarter,PHA,Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-07T15:39:05.630000-04:00
947949,4be36a2e-e651-4c4d-bbc7-55b08c6f5943,Q2,HANCE SCARBOROUGH,17443,TEXAS ACADEMY OF COMPOUNDING PHARMACISTS,2010,second_quarter,PHA,Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-07T15:54:11.083000-04:00
949157,c13e4b83-81c6-4543-939f-f7b25851228e,Q2,GREATER NEW YORK HOSPITAL ASSOCIATION,16830,GREATER NEW YORK HOSPITAL ASSOCIATION,2010,second_quarter,PHA,"Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590, P.L. 111-148; H.R.4872, P.L. 111-152); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239); H.R.4213)","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,420000,0,0,2010-07-09T15:01:48.987000-04:00
949367,8da22e6a-74d1-4d12-b8bd-f836685e2044,Q2,WINBORN SOLUTIONS LLC,308310,PERRIGO CO,2010,second_quarter,PHA,"Dextromethorphan Distribution Act of 2009
Legislation to regulate the sale of psuedoephedrine
Food and drug safety, user fee, and country of origin legislation","HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2010-07-10T20:23:21.673000-04:00
949482,3da19257-15ff-478f-8f17-8c1cf20d53f4,Q2,SQUIRE PATTON BOGGS,30906,KERR CORPORATION,2010,second_quarter,PHA,Issues related to FDA enforcement action against counterfeit medical devices.,HOUSE OF REPRESENTATIVES,,,0,0,2010-07-12T08:37:58.520000-04:00
950227,ee12142b-bfa8-481b-9d85-e1d1c4db0f63,Q2,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2010,second_quarter,PHA,"Proposals to place a moratorium on prescription drug advertising and requiring a ""fair balance"" between risk and benefit information in prescription drug advertisements
Proposals to extend FDA authority to over-the-counter drug advertisements
FDA proposed rule to implement requirements for ""major statement"" in DTC television or radio ads H.R. 2175 - Families for ED Decency Act, to prohibit the broadcast of drugs for erectile dysfuncton/male enhancement on indecency grounds","Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2010-07-12T17:03:51.513000-04:00
950449,c7e7c9bc-8274-4fa2-943b-bd14faf5ecfc,Q2,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2010,second_quarter,PHA,General issues affecting the pharmaceutical industry,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-07-13T09:17:15.203000-04:00
950853,ca047eaa-69a4-43f5-b17a-8b441b11e4c9,Q2,LOCKE LORD PUBLIC POLICY GROUP LLC,300971,MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES,2010,second_quarter,PHA,Pharmceutical performance reimbursement; biogenics,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-07-13T11:54:26.030000-04:00
951437,883146c8-8d38-4d09-961a-aef2ba090c82,Q2,MEREDITH MCGEHEE,79858,INTERNATIONAL AIDS VACCINE INITIATIVE,2010,second_quarter,PHA,Funding for programs to develop AIDS vaccines targeted toward the developing world; Working with Global Health Technologies Coalition to education on research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR; Appropriations for USAID R&D and funding for IAVI; Providing information on IAVI's Antibody Project and PDP model; Providing input on foreign assistance reform from a global health perspective,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-13T14:41:47.327000-04:00
952760,dab1145e-09a5-4787-805d-2ad1b25a1f64,Q2,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2010,second_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510).
Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-14T13:04:02.807000-04:00
953194,81672818-f1a3-4794-bad4-856dab98b6e6,Q2,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2010,second_quarter,PHA,"Antibiotics in animal foods
Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine.

S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA.

Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling.

Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act.

Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds.","Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-14T15:26:40.213000-04:00
953248,a433eeab-5d9d-4703-b796-705e25e4c6ad,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AMGEN USA INC.,2010,second_quarter,PHA,No specific issues or legislation during this reporting period.,,45000,,0,0,2010-07-14T15:33:56.683000-04:00
953679,dd550b8e-9fc9-4a6e-964a-e17e0489b31e,Q2,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2010,second_quarter,PHA,Controlled Drug Substances Act (21 USC 13),"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-14T18:43:52.573000-04:00
953895,2a109346-86e0-4a5b-9e1b-b7417246ec5c,Q2,JULIE PHILP,400407928,NATIONAL GRASSROOTS AND COMMUNICATION,2010,second_quarter,PHA,Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health plans; and create a fund to pay for prescription medicines for low-income individuals.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-15T10:02:37.497000-04:00
953915,f6e16e48-0063-452d-8971-60e3471910f5,Q2,THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK,309377,ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK,2010,second_quarter,PHA,Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescrption drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-15T10:14:42.247000-04:00
954289,25ae56da-e605-4d3c-baa0-f5f6688b8557,Q2,AMERICAN ADVERTISING FEDERATION,1411,AMERICAN ADVERTISING FEDERATION,2010,second_quarter,PHA,"Hr 3200, HR 3590, S 1679, S 1796, health care reform legislation as it affects the taxation or content of pharmaceutical advertising
HR 2175, to prohibit as indecent the broadcasting of any advertisement for a medication for the treatment of erectile dysfunction
Proposals to require a moratorium on the advertising of new prescription medications
Proposals to extend Food and Drug Administration authority to advertising for over-the-counter medications","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2010-07-15T11:51:32.467000-04:00
954666,ff8eb4b6-07da-4bb3-b2e7-426e172b5e50,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2010,second_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.

H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T13:42:33.073000-04:00
954686,1cd91d3a-4d90-4358-9e4a-5f84281f7ec9,Q2,"THE OB-C GROUP, LLC",29802,ELI LILLY,2010,second_quarter,PHA,No specific bill number: matters relating to pharmaceutical manufacturers.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-15T13:45:50.837000-04:00
954756,831cb22b-4b9e-4a79-8680-28bb40ebc165,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2010,second_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T14:00:06.603000-04:00
954825,a7ec478c-527a-4edd-89ef-cdcd59d0ce29,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2010,second_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.

H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T14:16:32.360000-04:00
955021,efcff0d1-b57e-44e4-99de-57c1784fd503,Q2,"VAN NESS FELDMAN, LLP",39815,MCKESSON CORPORATION,2010,second_quarter,PHA,"H.R. 3590, Patient Protection and Affordable Care Act
H.R. 4872, Health Care and Education Reconciliation Act of 2010
H.R. 3108, Medication Therapy and Management Benefits Act of 2009
S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-15T15:24:35.350000-04:00
955099,4cc586da-bc2c-41cc-bed8-dbc8307055d0,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2010,second_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.

H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T15:53:07.367000-04:00
955237,d597a90a-98f2-49cf-b272-f5843a4fd4e0,Q2,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2010,second_quarter,PHA,"Communications with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act reauthorization; communication with Office of Pharmacy Affairs, Health Resources and Services Administration on 340B drug pricing program, transition to new Director of Office of Pharmacy Affairs, Patient Safety and Clinical Services Collaborative, status of patient definition guidelines, increased federal funds for community health centers, National Healthcare Workforce Commission; Commmunication with FDA on distribution of medication guides in the inpatient setting; communication with FDA on drug recalls; communication with DEA on electronic prescriptions for controlled substances; meeting with HRSA's Office of Rural Health Policy to discuss medication therapy management, workforce commission, patient safety collaborative, telepharmacy, 340B and health IT.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2010-07-15T16:21:06.503000-04:00
955262,6684c130-7564-43f6-b398-8272ef839e16,Q2,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2010,second_quarter,PHA,"Importation of prescription drugs (S.525/H.R. 1298); Import Safety (H.R. 759); Rx Pedigree;
Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues - (H.R. 4489);
Drug Disposal","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,220000,0,0,2010-07-15T16:28:41.117000-04:00
955755,102a3236-7c53-4370-b2fe-3ef0162431ec,Q2,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2010,second_quarter,PHA,"H.R. 3590 Patient Protection and Affordable Care Act specifically
Average Manufacturer Price Pharmacy Reimbursement H.R. 3590
DMEPOS Pharmacy Accreditation H.R. 3590
PBM Transparency in Health Insurance ""Exchanges"" H.R. 3590 H.R. 5235, Medicare Access to Diabetes Supplies Act.
H.R. 3790 Repeal DMEPOS Competitive Bidding
H.R. 5234 The PBM Audit and Transparency Act of 2010","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2010-07-15T19:21:59.553000-04:00
955805,a8c113f2-4499-4582-bfdf-890115a99d31,Q2,NOVO NORDISK INC.,284790,NOVO NORDISK INC.,2010,second_quarter,PHA,"H.R. 1, American Recovery and Reinvestment Act of 2009, H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; issues regarding comparative effectiveness","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE",,375000,0,0,2010-07-15T20:32:29.363000-04:00
956342,a592281b-9114-4073-95c4-cf69a58d3cb3,Q2,UNIVERSITY OF CONNECTICUT,39382,UNIVERSITY OF CONNECTICUT,2010,second_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA Salaries and expenses; and extramural research related issues.","Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)",,70000,0,0,2010-07-16T10:51:57.813000-04:00
958339,755075ce-f55a-4c16-a45d-ed074459fbad,Q2,"TEVA PHARMACEUTICALS USA, INC.",76695,TEVA PHARMACEUTICALS USA INC,2010,second_quarter,PHA,"H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the ""doughnut hole"" impact; and implementation of healthcare reform legislation.","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Customs & Border Protection,U.S. Trade Representative (USTR)",,840000,0,0,2010-07-16T17:19:21.280000-04:00
958395,248299ff-f28d-4553-b042-d5c12fbd8c35,Q2,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2010,second_quarter,PHA,"Increased appropriations for systems to shorten the time between development of a drug and its release to the public.
FDA reform as it relates to drug development and research
Collaborative research on drug development                                 anti-malarial pharmaceuticals
FY 2010 Agricultural Appropriations                                             human factors research related to neuropharmaceuticals","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,110000,0,0,2010-07-16T17:28:41.297000-04:00
959396,a172d394-66ae-414d-a573-1a27005f24a7,Q2,SQUIRE PATTON BOGGS,30906,SUNOVION PHARMACEUTICALS INC,2010,second_quarter,PHA,Issues related to respiratory drug coverage and H.R. 3590.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-18T05:31:48.253000-04:00
959783,d85bcb74-6daa-4d6a-8eb7-3e31c69ab168,Q2,APOTEX CORP.,310973,APOTEX CORP.,2010,second_quarter,PHA,"S. 1315/HR 3777 the Drug Price Competition Act of 2009
S. 369, the Preserve Access to Affordable Generics Act
HR 4899 EAH, Supplemental Disaster Relief and Summer Jobs Act of 2010, Chapter 2,  Section 4201, Preserve Access to Affordable Generics Act SA 4361 to HR 4213 concerning market blockages caused by pharmaceutical patent settlements
HR 759, Food and Drug Administration Globalization Act of 2009
Pharmaceutical waste disposal","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2010-07-18T22:08:46.433000-04:00
959793,8edd6131-8b45-4258-a6ea-0dc49ac38084,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,ISIS PHARMACEUTICALS,2010,second_quarter,PHA,"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-07-18T22:19:54.593000-04:00
959808,d6692f0d-b60a-478a-aa28-b91864dbd27f,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,"ALLERGAN, INC.",2010,second_quarter,PHA,Issues related to Section 340B of the Public Health Service Act.,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-18T22:46:02.453000-04:00
959829,d9d04307-e7a1-4430-9ff5-8efc5deacbdd,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2010,second_quarter,PHA,Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2010-07-18T23:28:17.137000-04:00
960214,af0fe7df-54a7-4a76-a2a4-eef479b5d5e6,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF CONNECTICUT,2010,second_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues.","Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)",50000,,0,0,2010-07-19T06:57:21.357000-04:00
960221,8f2b3b00-fb25-43b8-afb6-a4f552a7a198,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE,2010,second_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA and USDA funding initiatives; Critical Path Partnership.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-19T06:58:23.540000-04:00
960292,e00f6d61-2c00-4ee3-87d0-2b1efe2a1c30,Q2,SANOFI US SERVICES INC.,56838,SANOFI US SERVICES INC,2010,second_quarter,PHA,Issues related to the TRICARE retail rebate program; issues related to the 340B Federal Drug Pricing Program,"Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,870000,0,0,2010-07-19T09:01:39.050000-04:00
960305,4657efed-4f99-4c23-a1a7-46b0c5bf262b,Q2,EISAI INC.,400321512,EISAI INC.,2010,second_quarter,PHA,"biosimilars, follow-on biologics
S 726 Promoting Innovation and Access to Life-Saving Medicine Act
HR 3590 Patient Protection and Affordable Care Act
HR 4872 Health Care and Education Reconciliation Act of 2010","HOUSE OF REPRESENTATIVES,SENATE",,1060000,0,0,2010-07-19T09:07:45.277000-04:00
960489,09d38b09-29ac-46e9-9446-62fec36de603,Q2,AKIN GUMP STRAUSS HAUER & FELD,682,"PRASCO, INC.",2010,second_quarter,PHA,Promoting consumer benefits of authorized generic drugs,"Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-19T09:52:42.163000-04:00
960902,69d870ac-b3ce-48cf-b1f5-9f5eb6d0071b,Q2,AMERICAN VETERINARY MEDICAL ASSOCIATION,3630,AMERICAN VETERINARY MEDICAL ASSOCIATION,2010,second_quarter,PHA,"HR 1549/S 619, Preservation of Antibiotics for Medical Treatment Act
HR 2400, Strategies to Address Antimicorbial Resistance (STAAR) Act","Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,110000,0,0,2010-07-19T10:57:56.953000-04:00
961172,6d90bbd7-901c-4a97-9f66-6340f033f372,Q2,"WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC",41113,"JARROW FORMULAS, INC.",2010,second_quarter,PHA,"Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius;  S. 510 and the Dietary Supplement Health and Education Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-19T11:23:55.780000-04:00
961694,90782503-1dcf-4071-a247-9997dc55b452,Q2,THE DUBERSTEIN GROUP INC.,12675,AMERICA'S HEALTH INSURANCE PLANS,2010,second_quarter,PHA,"*Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009.
*Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act. *Generic biologics - HR 3590, Patient Protection and Affordable Care Act.

*Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act.

*Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009.","HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",100000,,0,0,2010-07-19T12:12:35.030000-04:00
961717,bd064733-b756-45ae-b840-3f683e16c114,Q2,"GREENBERG TRAURIG, LLP",16896,"RICHIE & GUERINGER, P.C.",2010,second_quarter,PHA,Congressional actions on health care reform.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-19T12:14:43.620000-04:00
961884,58738edf-6eb7-4493-84b4-6e65fee071b1,Q2,THE DUBERSTEIN GROUP INC.,12675,NORVARTIS CORP,2010,second_quarter,PHA,"Pandemic funding - HR 4899, Supplemental Appropriations Act, 2010.",SENATE,100000,,0,0,2010-07-19T12:33:56.753000-04:00
962328,1b0141a2-8faf-4f94-b3b2-8a27e6feb600,Q2,SMITH GARSON FKA SMITH DAWSON & ANDREWS,35707,PROSETTA CORPORATION,2010,second_quarter,PHA,Government Advertisement of Biopharmaceuticals,SENATE,7500,,0,0,2010-07-19T13:25:23.957000-04:00
962445,dffa6c27-f572-43aa-a040-373f7026d119,Q2,SMITH GARSON FKA SMITH DAWSON & ANDREWS,35707,STRUVE SWINE TECHNOLOGIES,2010,second_quarter,PHA,Government Advertisement of Biopharmaceuticals,SENATE,,,0,0,2010-07-19T13:36:07.817000-04:00
962450,4c58f2a2-1821-46ba-bdca-124127016b76,Q2,"GREENBERG TRAURIG, LLP",16896,GENERIC PHARMACEUTICAL ASSOCIATION,2010,second_quarter,PHA,Representation on international trade issues affecting generic pharmaceutical industry.,"HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)",10000,,0,0,2010-07-19T13:37:09.117000-04:00
962841,5cf0d963-3868-4088-99ea-9e1fb782e6d5,Q2,EVERTZ GROUP LLC,400497446,MYLAN INC.,2010,second_quarter,PHA,Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program.,"Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID)",30000,,0,0,2010-07-19T14:05:14.583000-04:00
963163,4781f20d-1077-4e7b-bdd0-e275c4ae1e57,Q2,TARPLIN STRATEGIES LLC,40032282,"GENENTECH, INC.",2010,second_quarter,PHA,"Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare prescription drug benefit.
H.R. 4213, the American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes related to the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit.","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2010-07-19T14:28:29.987000-04:00
963218,1afdc158-a86f-4727-b334-2f89898a4854,Q2,FOLEY & LARDNER LLP,15042,"ROMARK LABORATORIES, LC",2010,second_quarter,PHA,Sale of new anti-viral drug,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-19T14:32:28.127000-04:00
963223,f1097175-4378-42b4-a3aa-66c9ff69a820,Q2,APOTEX CORP.,310973,APOTEX CORP.,2010,second_quarter,PHA,"S. 1315/HR 3777 the Drug Price Competition Act of 2009
S. 369, the Preserve Access to Affordable Generics Act
HR 4899 EAH, Supplemental Disaster Relief and Summer Jobs Act of 2010, Chapter 2,  Section 4201, Preserve Access to Affordable Generics Act SA 4361 to HR 4213 concerning market blockages caused by pharmaceutical patent settlements
HR 759, Food and Drug Administration Globalization Act of 2009
Pharmaceutical waste disposal","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2010-07-19T14:32:30.363000-04:00
963308,fdee0cf1-7480-41a1-b928-035e0a8307d3,Q2,AARP,1694,AARP,2010,second_quarter,PHA,"S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad.
S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs.
H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes.
S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability.  Specifically, AARP weighed in on the inequitable conduct provisions of the legislation.
S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians.
S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of ""first applicant"" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug.
H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports.
H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.","Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office",,4250000,0,0,2010-07-19T14:38:48.247000-04:00
963444,112a7cc6-7ff3-481b-a5e1-2f32634d6cf7,2A,APOTEX CORP.,310973,APOTEX CORP.,2010,second_quarter,PHA,"S. 1315/HR 3777 the Drug Price Competition Act of 2009
S. 369, the Preserve Access to Affordable Generics Act
HR 4899 EAH, Supplemental Disaster Relief and Summer Jobs Act of 2010, Chapter 2,  Section 4201, Preserve Access to Affordable Generics Act SA 4361 to HR 4213 concerning market blockages caused by pharmaceutical patent settlements
HR 759, Food and Drug Administration Globalization Act of 2009
Pharmaceutical waste disposal","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2010-07-19T14:48:52.140000-04:00
963497,45b30691-7cda-4d65-be91-929994b9a54e,2A,AARP,1694,AARP,2010,second_quarter,PHA,"S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad.
S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs.
H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes.
S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability.  Specifically, AARP weighed in on the inequitable conduct provisions of the legislation.
S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians.
S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of ""first applicant"" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug.
H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports.
H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.","Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office",,4250000,0,0,2010-07-19T14:52:11.133000-04:00
963825,de1ae31f-5e4c-45f6-827c-76f2376fa07e,Q2,"PODESTA GROUP, INC.",31680,BRISTOL-MYERS SQUIBB,2010,second_quarter,PHA,"Drug Importation/Drug Safety
H.R. 3590 Patient Protection and Affordable Care Act
H.R. 4872 Health Care and Education Reconciliation Act of 2010","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-19T15:14:25.977000-04:00
963930,a8d09995-9922-43da-8fa4-3db52392ab9b,Q2,"PODESTA GROUP, INC.",31680,CUBIST PHARMACEUTICALS INC,2010,second_quarter,PHA,"Medical Research
Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues
Antibiotic Resistance Issues
H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 MRSA Infection Prevention and Patient Protection Act
S. 369 Preserve Access to Affordable Generics Act of 2009","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-07-19T15:21:01.417000-04:00
964167,665a1c72-a2cd-45cb-8d2a-cb20ed7273c2,Q2,"PODESTA GROUP, INC.",31680,EISAI INC.,2010,second_quarter,PHA,"S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 3590 Patient Protection and Affordable Care Act
H.R. 4872 Health Care and Education Reconciliation Act of 2010","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-07-19T15:33:18.283000-04:00
964251,af035938-25e7-4700-90be-383a073f3624,Q2,"PODESTA GROUP, INC.",31680,MILLENNIUM PHARMACEUTICALS INC,2010,second_quarter,PHA,"S. 717  21st Century Cancer ALERT (Access to Life Saving Early detection, Research and Treatment) Act
H.R. 3590 Patient Protection and Affordable Care Act
H.R. 4872 Health Care and Education Reconciliation Act of 2010","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-19T15:36:41.090000-04:00
964366,da4b40e8-9f82-445d-8f8a-9448ab517305,Q2,"PODESTA GROUP, INC.",31680,NOVO NORDISK INC,2010,second_quarter,PHA,"Drug Importation
H.R. 3590 Patient Protection and Affordable Care Act
H.R. 4872 Health Care and Education Reconciliation Act of 2010","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",60000,,0,0,2010-07-19T15:42:20.030000-04:00
964415,20424092-e58a-44b9-8032-7183db49f59c,Q2,"AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES",2321,AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES,2010,second_quarter,PHA,Health Care Reform Law Implementation,"Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,740000,0,0,2010-07-19T15:44:38.637000-04:00
964539,1f3b2cc1-7ebd-4fbf-85a3-10264209a9c8,Q2,WINSTON & STRAWN LLP,41682,TEVA PHARMACEUTICALS USA,2010,second_quarter,PHA,Biogenerics,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-19T15:51:16.433000-04:00
964762,46e9accf-60a9-4be9-9fad-1437c5145b3d,Q2,WINSTON & STRAWN LLP,41682,WOCKHARDT USA LLC,2010,second_quarter,PHA,Generic drug issues - preemption; FTC settlements,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-19T16:03:41.357000-04:00
964816,e42ce731-7548-4405-a5ce-22c7a5fcbd2a,Q2,UNIVERSITY OF KANSAS,321373,UNIVERSITY OF KANSAS,2010,second_quarter,PHA,"Briefing on nanotechnology research for inhaled pharmaceuticals and  applicaiton for chemical, biological, radiation, and nuclear responses. Requested statement for congressional hearing related to the University of Kansas and its pharmaceutical research program in neglected and rare diseases.","Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,47500,0,0,2010-07-19T16:07:05.837000-04:00
964901,2078b7ea-8035-4b8f-8b57-75ba6f85ca01,Q2,CVS HEALTH (AND SUBSIDIARIES),302778,CVS CAREMARK INC,2010,second_quarter,PHA,Pharmacy  Issues related to drug safety and the tracking of drug suppliers.,"HOUSE OF REPRESENTATIVES,SENATE",,2250000,0,0,2010-07-19T16:12:33.443000-04:00
965190,a5206338-c3a2-44c2-a9ac-0b5609351772,Q2,"EXPRESS SCRIPTS, INC.",294416,"EXPRESS SCRIPTS, INC.",2010,second_quarter,PHA,"Items related to reverse settlement payments between manufacturers--HR 1706, S 369
Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489
Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,410000,0,0,2010-07-19T16:36:01.303000-04:00
965385,6b00fd4f-70b1-4d13-96e9-84273c2eda79,Q2,OREGON HEALTH & SCIENCE UNIVERSITY,30291,OREGON HEALTH & SCIENCE UNIVERSITY,2010,second_quarter,PHA,Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 444/S 1239); American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213).,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Vice President of the U.S.",,90000,0,0,2010-07-19T16:49:10.460000-04:00
965412,ad18a2b0-991c-4e6f-af10-683e9396aa3e,Q2,WINSTON & STRAWN LLP,41682,FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ),2010,second_quarter,PHA,"Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-19T16:52:21.267000-04:00
965469,3446857a-880a-4211-a214-8e58e0ee530d,Q2,AMYLIN PHARMACEUTICALS,308536,AMYLIN PHARMACEUTICALS,2010,second_quarter,PHA,"Physician Payments Sunshine provision of Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010)
FDA Risk Evaulation Mitigation Strategies (REMS)
Drug Safety Communications
Drug importation issues","HOUSE OF REPRESENTATIVES,SENATE",,240000,0,0,2010-07-19T16:57:15.527000-04:00
965508,310d5fbf-dbd5-4937-987a-44cd0f5c20a9,Q2,"MEHLMAN CONSULTING, INC.",284950,MERCK AND CO INC,2010,second_quarter,PHA,"Support efforts to ensure appropriate access to vaccines and preventive care.  Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage.  Issues related to The Implementation of the FDAAA of 2007.  Issues relating to importation of prescription drugs.","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-19T17:02:03.960000-04:00
965512,d8044c76-bfdb-4c03-8ed3-725348fa4406,Q2,ACADEMY OF MANAGED CARE PHARMACY,48793,ACADEMY OF MANAGED CARE PHARMACY,2010,second_quarter,PHA,Legislation relating to to pharmacy issues and the professional role of pharmacists; legislation relating to medication therapy management programs and funding for said programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally.,"HOUSE OF REPRESENTATIVES,SENATE",,155000,0,0,2010-07-19T17:02:24.017000-04:00
965712,40e5611a-03d5-4a78-a62e-765edd35578a,Q2,AMERICAN HEALTH CARE ASSOCIATION,2491,AMERICAN HEALTH CARE ASSOCIATION,2010,second_quarter,PHA,"Updating controlled sustances regulations for long-term care. 
 S.3397: Secure and Responsible Drug Disposal Act of 2010.","Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE",,480000,0,0,2010-07-19T17:16:00.397000-04:00
965821,804b9495-d9ad-4a66-af94-dfab6b477601,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF MARYLAND BALTIMORE,2010,second_quarter,PHA,No lobbying activity.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-19T17:26:40.377000-04:00
966741,a306523f-dfb0-4df9-b161-d7516341ca55,Q2,KAISER FOUNDATION HEALTH PLAN INC.,21027,KAISER FOUNDATION HEALTH PLAN INC,2010,second_quarter,PHA,"S 726 Promoting Innovation and Access to Life-Saving Medicine Act
To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products.
Sponsor: Schumer (D-NY)","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,140000,0,0,2010-07-19T19:39:49.010000-04:00
966842,f578c8bb-b46a-43e4-bb28-a06ff83f6605,2T,POLICY ADVOCATES,72018,PHOENIX CAPITAL MANAGEMENT LLC,2010,second_quarter,PHA,Track and monitor Internet Pharmacy Issues.,"HOUSE OF REPRESENTATIVES,SENATE",13500,,0,1,2010-07-19T20:16:22.970000-04:00
966922,a701d91e-28b6-4fdb-a767-e5f91971bf5f,Q2,WALMART INC.,40305,WALMART INC,2010,second_quarter,PHA,"H.R. 5234, PBM Audit Reform and Transparency Act of 2010, to ensure transparency and proper operation of pharmacy benefit managers","Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Federal Highway Administration (FHA),Federal Motor Carrier Safety Administration,Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Labor, Dept of (DOL),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR),White House Office",,1430000,0,0,2010-07-19T20:42:12.890000-04:00
967069,cc56e002-e8f9-43e3-af5e-0bfd63558e6e,Q2,OGR,48827,SANOFI PASTEUR,2010,second_quarter,PHA,vaccine related issues,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-19T22:08:45.803000-04:00
967114,ed63e2a4-f148-4cf0-a459-f7e539ca47a5,Q2,"PODESTA GROUP, INC.",31680,GENZYME,2010,second_quarter,PHA,"H.R. 3156 Neglected Disease Tax Credit Bill
H.R. 3590 Patient Protection and Affordable Care Act
H.R. 4872 Health Care and Education Reconciliation Act of 2010","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2010-07-19T22:46:06.730000-04:00
967582,81113808-f3a1-4b80-bc6c-870a533d93c4,Q2,ACG ADVOCACY,2057,"PFIZER, INC.",2010,second_quarter,PHA,"Followon Biologics
Super MedPAC
HRSA - 340B Drug Pricing Program/Pharmacy Affairs","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-20T07:26:33.593000-04:00
967671,f1168b53-20d0-498a-af93-4dd32eac1fd1,Q2,INDEPENDENCE BLUE CROSS,19172,INDEPENDENCE BLUE CROSS,2010,second_quarter,PHA,"HR 4489 ""FEHBP Prescription  Drug Integrity, Transparency, and Cost Savings Act""; Pharmacy Antitrust 
pharmacy antitrust issues","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-20T08:06:03.887000-04:00
967680,aea864e0-cc69-4378-b751-e417b79926ee,Q2,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2010,second_quarter,PHA,"Patent Settlements H.R. 1432, Genetic Biologics  S. H.R. 1695, H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R.  1908, Import Safety Act H.R. 3100
Affordable Health Choices Act",,105000,,0,0,2010-07-20T08:15:17.553000-04:00
967702,d396a0f9-3300-475b-9fc5-53981deaa097,Q2,"RUBICON ADVISORS, LLC",315091,WATSON PHARMACEUTICALS INC,2010,second_quarter,PHA,"Patent Reform H.R. 1908, Import Safety Act H.R. 2100             Affordable Health Choices Act
Patent Settlements H.R. 1432 S. 316
Generic Biologics S. 1685 H.R. 5629
Physician Payment Sunshine Act S. 2029",,98000,,0,0,2010-07-20T08:19:26.593000-04:00
967730,1985a83c-dee6-417b-be83-194ed30305a3,Q2,"RUBICON ADVISORS, LLC",315091,"BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.",2010,second_quarter,PHA,"Physiciam Payment Sunshine Act S 2029
Patent Settlements H.R. 14328 .316
Affordable Healthcare Choices Act",,30000,,0,0,2010-07-20T08:24:33.010000-04:00
967743,00c2451f-6408-405d-b475-99360e2f83c5,Q2,U.S. CHAMBER INSTITUTE FOR LEGAL REFORM,51172,U S CHAMBER INSTITUTE FOR LEGAL REFORM,2010,second_quarter,PHA,"S. 540/H.R. 1346, Medical Device Safety Act of 2009

General background on drug and device labeling rules and the doctrine of Federal preemption (no specific legislation introduced)","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Securities & Exchange Commission (SEC),SENATE",,3750000,0,0,2010-07-20T08:27:31.987000-04:00
967766,24a48d4d-b862-47a9-84eb-fb697e2ebf76,Q2,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2010,second_quarter,PHA,"H.R. 822, H.R. 1943, H.R. 6114, S-2969",,75000,,0,0,2010-07-20T08:28:40.520000-04:00
967775,bc90051a-23a1-4e1a-a563-b58cfaea94dd,Q2,"RUBICON ADVISORS, LLC",315091,INSMED INCORPORATED,2010,second_quarter,PHA,"Generic Biologics S. 1695
Affordable Health Care Choices Act",,22500,,0,0,2010-07-20T08:32:46.347000-04:00
967815,09c9209f-c561-47aa-8fd7-af9e36b58890,Q2,CHAMBER OF COMMERCE OF THE U.S.A.,38756,CHAMBER OF COMMERCE OF THE U.S.A.,2010,second_quarter,PHA,"H.R. 1346/S. 540,  Medical Device Safety Act of 2009
H.R. 3590, Patient Protection and Affordable Care Act","Agriculture, Dept of (USDA),Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Council on Environmental Quality (CEQ),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Maritime Administration (MARAD),Natl Aeronautics & Space Administration (NASA),Natl Economic Council (NEC),Natl Institute of Standards & Technology (NIST),Natl Labor Relations Board (NLRB),Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),St. Lawrence Seaway Development Corporation,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office",,9480000,0,0,2010-07-20T08:36:35.797000-04:00
967831,0a42a425-2e48-474a-aed3-6fb2ef6de648,Q2,"RUBICON ADVISORS, LLC",315091,OSMOTICA PHARMACEUTICALS,2010,second_quarter,PHA,"FDA Citizen Petition Reform
Affordable Healthcare Choices Act",,35000,,0,0,2010-07-20T08:36:54.573000-04:00
967916,0eb0b166-afc9-4ec8-97e2-fc3136e49db2,Q2,"CAPITOL STRATEGIES GROUP, LLC",400462294,PHRMA (ON BEHALF OF WE WORK FOR HEALTH ),2010,second_quarter,PHA,-The impact of medical innovation on the economy,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-20T08:49:06.413000-04:00
968191,cb4ed426-ebeb-4a35-b9d4-62913212a3b6,Q2,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,29403,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2010,second_quarter,PHA,"Issues related to methamphetamine precursor chemicals
HR 759, S 882 - regarding the manufacturing and import of OTC drugs","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE",,1687444,0,0,2010-07-20T09:21:37.497000-04:00
968281,aea7b35c-53e3-4814-812b-d2eabd64e959,Q2,"OMNICARE, INC.",321112,OMNICARE INC,2010,second_quarter,PHA,Issues related to controlled substances distribution and accountability in skilled nursing facilities,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,88000,0,0,2010-07-20T09:31:57.577000-04:00
968349,be4d63eb-be9e-4b15-9fe4-df7be408580f,Q2,DLA PIPER LLP (US),76855,SANOFI PASTEUR,2010,second_quarter,PHA,"Pandemic influenza, vaccine-related issues.","Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-20T09:37:56.450000-04:00
968406,2727e376-4628-4e29-a227-b90076a6f6dc,Q2,340B HEALTH,316434,340B HEALTH,2010,second_quarter,PHA,S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity.  Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,191519,0,0,2010-07-20T09:42:12.523000-04:00
968525,87ce1c44-4c58-48c5-a4fc-2977fc77cfbe,Q2,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2010,second_quarter,PHA,"H.R. 3590, Patient Protection and Affordable Care Act
H.R. 4872, Reconciliation Act of 2010
H.R. 616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations.
H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program.
H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program.
H.R. 3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs.
S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine.
S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements.
H.R. 2221, Data Accountability and Trust Act, as related to provider privacy requirements.
H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparancy, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP.
S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.
S. 3532, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,420000,0,0,2010-07-20T09:47:17.813000-04:00